Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
49.35    -2.35 (-4.55%)
Bid:
48.45
Ask:
49.00
Spread: 0.55 (1.135%)
Market Cap: £647.76m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Trading Update and comment on US Entity List

24 May 2019 07:00



Trading Update and comment on US Entity List

IQE plc

Cardiff, UK. 24th May 2019: IQE plc (AIM: IQE; "IQE", the “Company” or the "Group"), the leading global supplier of advanced wafer products and materials solutions to the semiconductor industry, provides the following trading update in response to action taken by the Bureau of Industry and Security (BIS) of the United States Department of Commerce to add Huawei Technologies Co., Ltd. and 68 of its affiliates (“Huawei”) to the “Entity List” maintained by the Department. The BIS action prohibits the sale to Huawei, by certain of IQE’s customers, of products covered by the Export Administration Regulations (EAR) absent obtaining an appropriate export license.

IQE wishes to clarify its potential exposure to this rapidly evolving situation, as it supplies epitaxial wafers to multiple chip companies in global supply chains, some of whom supply Huawei.

The situation involving the ban is dynamic and it is not clear at this time how long it will remain in force or what the full implications will be. However, IQE believes it is in a strong position to adjust to the possible consequences and scenarios resulting from this in a positive manner. Across all product lines, IQE has supply relationships with multiple non-US customers, so is well placed to adapt to mid to long-term share shifts at both the component (chip) and the OEM level. The majority of IQE’s technologies and supply chains are not affected by the ban and IQE complies fully with the EAR.

In the short-term, IQE believes it may experience some delay to orders and the potential for adjustment of supplier managed inventory levels, predominantly in its Wireless Business Unit. The Photonics and Infrared Business Units are essentially unaffected.

The company has been engaging across its customer base in recent days specifically on this subject and estimates that its current maximum risk exposure to this matter is less than 5% of total FY 2019 revenue guidance.

Although there remains uncertainty and unpredictability related to this specific matter, given the market opportunity IQE faces in H2, the company leaves full year guidance unchanged.

Dr Drew Nelson, Chief Executive of IQE, said:

‘The recent ban on sales of products from US companies to Huawei and its affiliates is a factor completely outside of IQE’s control. However, our long-term strategy of supplying as many of the supply chains into all major OEMs as possible, protects IQEs overall supply to a very significant degree. As a result, we believe the ban will have a limited impact on our mid to long term revenue trajectory. Indeed, the breadth of IQE’s current product range, the new materials technologies being introduced to market over the coming months and years, and IQE’s global manufacturing footprint are powerful mitigating factors in dealing effectively with the ongoing changing geopolitical landscape in our industry."

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

CONTACTS:

  
  
  

IQE plc +44 (0) 29 2083 9400Tim PullenDrew NelsonChris Meadows Canaccord Genuity (Nomad and Joint Broker) + 44 (0) 20 7523 8000Simon BridgesRichard Andrews

Peel Hunt (Joint Broker) +44 (0) 20 7418 8900Edward KnightNick Prowting

ABOUT IQE

http://iqep.com IQE is the leading global supplier of advanced semiconductor wafers that enable a diverse range of applications, supported by an innovative outsourced foundry services portfolio that allows the Group to provide a 'one stop shop' for the wafer needs of the world's leading semiconductor manufacturers. IQE uses advanced crystal growth technology (epitaxy) to manufacture and supply bespoke semiconductor wafers 'epi-wafers' to the major chip manufacturing companies, who then use these wafers to make the chips which form the key components of virtually all high technology systems. IQE is unique in being able to supply wafers using all of the leading crystal growth technology platforms. IQE's products are found in many leading-edge consumer, communication, computing and industrial applications, including a complete range of wafer products for the wireless industry, such as smartphones and wireless infrastructure, Wi-Fi, base stations, and satellite communications; optical communications, optical storage, printing, thermal imagers, leading-edge medical technologies, automotive and aerospace technologies, a variety of advanced silicon based systems and high efficiency concentrator photovoltaic (CPV) solar cells. IQE is headquartered in Cardiff UK and operates multiple manufacturing and R&D facilities worldwide.


Date   Source Headline
3rd Jun 20265:37 pmRNSIQE plc: Holding(s) in Company
3rd Jun 20267:00 amRNSIQE plc: Notice of AGM and Annual Report
2nd Jun 202612:09 pmRNSIQE plc: Total Voting Rights
1st Jun 20264:21 pmRNSHolding(s) in Company
29th May 20269:46 amRNSIQE plc: Director/PDMR Shareholding
28th May 20267:05 amRNSIQE plc: FY 2025 Financial Results
28th May 20267:00 amRNSIQE plc: Completion of Fundraising
20th May 20267:00 amRNSIQE plc: Notice of Results
18th May 20269:31 amRNSIQE plc: Holding(s) in Company
15th May 202612:14 pmRNSIQE plc: Results of General Meeting
14th May 202611:29 amRNSIQE plc: Holding(s) in Company
12th May 20262:14 pmRNSIQE plc: Holding(s) in Company
11th May 202612:38 pmRNSIQE plc: Holding(s) in Company
7th May 20264:59 pmRNSIQE plc: Holding(s) in Company
6th May 20262:16 pmRNSIQE plc: Holding(s) in Company
5th May 202612:00 pmRNSIQE plc: Holding(s) in Company
1st May 20267:00 amRNSIQE plc: Total Voting Rights
30th Apr 20268:33 amRNSForm 8.3 IQE PLC 20260429
29th Apr 20262:55 pmRNSForm 8.3 IQE PLC
29th Apr 20261:05 pmRNSIQE plc: Circular & Notice of General Meeting
29th Apr 20267:00 amRNSForm 8.3 IQE PLC 20260428
28th Apr 20263:00 pmRNSForm 8.3 IQE PLC
28th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
28th Apr 20269:19 amRNSForm 8.3 IQE PLC 20260427
28th Apr 20267:45 amRNSDisclosure Table
28th Apr 20267:00 amRNSIQE plc: Results of Placing and Retail Offer
28th Apr 20267:00 amRNSForm 8.3 - IQE PLC - PengXi Capital Limited
27th Apr 20265:00 pmRNSIQE plc: RetailBook Offer
27th Apr 20264:55 pmRNSIQE plc: Conclusion of Strategic Review
27th Apr 202612:48 pmRNSForm 8.3 IQE PLC
27th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
27th Apr 202611:40 amRNSForm 8.5 (EPT/RI) IQE PLC - Replacement
27th Apr 202610:25 amRNSForm 8.5 (EPT/RI) - IQE plc
27th Apr 20267:00 amRNSIQE plc: Rule 2.9 Announcement
24th Apr 20261:56 pmRNSForm 8.3 IQE PLC
24th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
24th Apr 202611:40 amRNSForm 8.3 - IQE Plc
24th Apr 202611:12 amRNSForm 8.5 (EPT/RI) - IQE plc
24th Apr 202610:41 amRNSForm 8.3 IQE PLC 20260423
23rd Apr 20262:58 pmRNSForm 8.3 IQE PLC
23rd Apr 20262:22 pmRNSForm 8.3 - IQE PLC
23rd Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
23rd Apr 202610:09 amRNSForm 8.5 (EPT/RI) - IQE plc
23rd Apr 20268:45 amRNSIQE plc: Rule 2.9 Announcement
22nd Apr 20262:23 pmRNSForm 8.3 IQE PLC
22nd Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
22nd Apr 202611:15 amRNSIQE plc: Rule 2.9 Announcement
22nd Apr 20269:43 amRNSForm 8.3 IQE PLC 20260421
22nd Apr 20268:47 amRNSForm 8.3 - IQE PLC
21st Apr 20262:53 pmRNSForm 8.3 - IQE Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.